A Phase 1b/2, Open-Label Trial to Assess the Safety and Preliminary Efficacy of Epcoritamab (GEN3013; DuoBody®-CD3xCD20) in Combination with Other Agents in Subjects with B-cell Non-Hodgkin Lymphoma

Principal investigator: Sirpa Leppä
Trial site: HUS Comprehensive Cancer Center

Link to the ClinicalTrials.gov study website